Clinical Audit

Clinical audit is a crucial part of the Trust’s strategy to improve health care to service users. The evaluation of clinical performance against standards or through comparative analysis, with the aim of informing the management of services, is an essential component of modern healthcare provision. It forms part of the Trust’s clinical governance arrangements helping to ensure safe and effective clinical practices.

During 2022/23, EEAST participated in 100% of all required national audits which for ambulances are those defined within the Ambulance Clinical Quality Indicator (ACQI) programme, three of which: stroke; cardiac arrest and STEMI were included earlier in this section. It also fully participated in the National epidemiology and Outcome from out-of-Hospital Cardiac Arrest (OHCA) registry study undertaken by the University of Warwick and is included as an audit within the Healthcare Quality Improvement Partnership (HQIP) annual programme.

The fourth ACQI relates to Sepsis, a description of which is provided below along with EEAST’s performance compared against the national average and upper and lower scores.

 

Recognition and treatment of sepsis and neutropenic sepsis 

Although recognition of sepsis by our staff has a high compliance rate, we were seeking to continue to achieve a sustained high level of recognition and appropriate treatment for sepsis patients, recognising that early recognition, timely interventions and transportation to hospital is a key factor for the patient’s outcome.

The care bundle is made up of four indicators which all have to be met to be compliant:

  1. Recording of patient observations (breathing rate, level of consciousness and blood pressure)
  2. Administration of oxygen
  3. Administration of fluids
  4. Pre-alert provided to the receiving hospital.

This ACQI was removed from the national programme in July 2022, the table below demonstrates our performance for the care bundle against national data published for the year to this date. EEAST was the third highest performing trust for this ACQI. 

 

Sepsis CareNational Data (April to November 2022)
National AverageHighest ScoreLowest ScoreEEAST
Sepsis care bundle 84.6% 95.1% 67.3% 92.8%

Local Audits 2022/23 

Undertaking audit in relation to the nationally mandated Ambulance Clinical Quality Indicators relating to cardiac arrest, stroke, STEMI and sepsis patients is a huge amount of work, however in 2022/23 we also undertook nine further audits as defined within our set plan for the year. The table below shows the audit topic, levels of compliance, identified areas requiring improvement and next steps to improve the quality of care we deliver.

Topic Compliance Areas for improvement Next steps
Management of Abdominal Pain – Pilot Audit Overall care bundle compliance – 50% Documentation of pain scores

Referral to another HCP where indicated
Re-audit 2023/24 – increase care bundle by 25%+


Asthma – Re-audit




Overall care bundle compliance – 66.8%



Recording of oxygen saturation levels including where the patient was unable to provide one

Documentation of Beta-2agonist administered
Re-audit 2023/24 – increase care bundle by 25%




Use of Antimicrobials - Pilot Audit 6/8 indicators achieved 100% compliance Recording of:
- Blood glucose level
- News2 score
Re-audit 2023/24 to include additional indicators relating to actual News2 score and whether the patient had any history of diabetes
Deliberate Self Harm Overall care bundle compliance – 71.3% Documentation of:
- Mental capacity assessment
- Information relating to social/family support network or Next of Kin
Re-audit 2023/24 – increase care bundle by 20%

Inclusion of the completion and quality of documentation within the mental capacity assessment forms
Assessment and Management of Maternity including use of Misoprostol and Tranexamic Acid – Pilot Audit High levels of compliance for:

Observations, timeframe for bleeding and total blood loss
Documentation of:
− Uterine massage
− Administration of uterotonic drug (misoprostol) ahead of administration of tranexamic acid
− Separate patient care record for baby
Re-audit 2023/24 – longer audit period to ensure larger data capture
Re-audit of PCR Submission







Submission rate - 97.9%

Records completed electronically – 93.4%

Documentation of clinical impression code – 93.1% overall. Completed in 99.1% of electronic records
Documentation of clinical impression code to be increased, however this achieved higher levels of compliance when an electronic record was completed. Due to the ongoing increase of the use of electronic vs paper records, this should also improve. Audit will not be repeated in 2023/24, however a new audit of the quality of documentation will be introduced.




Trauma – Use of Tranexamic Acid – Re-audit








High levels of compliance for:

Observations, timeframe for bleeding and total blood loss, administration of oxygen and hospital pre alerts






Documentation of pain scores

A number of patients were given this drug by another HCP meaning that the true usage administered by EEAST staff is inaccurate.

There seems to be some confusion for staff regarding the difference between JRCALC guidelines and Trust Patient Group Directives as to bolus
Results of audit will be discussed with the Trust’s Trauma Lead, Medical Director and Pharmacist to identify actions for implementation.

Topic to be re-audited in 2023/24 once actions have been implemented.



Non-Conveyance
Paediatric Patients – Pilot Audit


9/11 indicators achieved compliance level of above 95%

High levels of safety netting
Documentation of:

- Blood glucose level
- Educational facility

Worsening advice given
Re-audit 2023/24 with the aim of increasing the remaining to indicators to 95%.



A further three audits were not completed in the year;

  • Falls in the elderly. This will be undertaken as part of a new national ACQI in 2023/24. EEAST currently participating in the pilot audit. National commencement date to be set by NHS England.
  • Mental health. Awaiting further information from NHS England regarding commencement and requirements.
  • Learning difficulties. This has been included as a priority within the clinical audit plan for 2023/24.

As well as an extensive clinical audit plan, the Trust undertakes a number of routine monthly audits for topics such as infection prevention and control and the management of medicines to ensure that patients and staff remain protected and we remain compliant with legislation.

 

Next Page: Participation in research

Back to Contents

 

Back to Top